Search Results
Debate: Optimal approach for the management of CLL patients with del(17p) - Novel Agents
Debate: Optimal approach for the management of CLL patients with del(17p) - Ibrutinib
CLL: Optimal approaches for patients with deletion 17p
Treatment options for the young CLL patient with deletion 17p: Do they need a different approach?
Debate: Best Approach for Multiple Relapsed CLL after Chemoimmunotherapy - Other Novel Agents
First Line Treatment of CLL
Combination of Novel Agents in CLL: Is this the Final Answer?
Novel Treatment Options in CLL
Debate: Best Approach for Multiple Relapsed CLL after Chemoimmunotherapy - Kinase inhibitor
Debate: Will novel-agent based combination therapy become standard of care for CLL? - No
Debate: Best Frontline Regimen for a CLL Patient Aged 60 Who Requires Therapy - FCR
Debate: Which is the optimal approach for CLL? - BR
